MedPath

Life Quality and Mental State in Patients With Breast Cancer

Phase 4
Completed
Conditions
Breast Cancer
Interventions
Other: Individualized complementary medicine treatment
Other: Individualized usual care
Registration Number
NCT01458457
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

Randomized pragmatic trial to evaluate the comparative effectiveness regarding disease specific quality of life of an individualized additional complementary medicine treatment in addition to usual care with usual care only in 280 women with breast cancer

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
275
Inclusion Criteria
  • diagnosed breast cancer
  • current usual care treatment
  • willing to refrain from complementary treatment for 6 months in case of randomization into the usual care group
  • informed consent
Exclusion Criteria
  • complementary treatment at the Hospital Meran in the last 6 months
  • no German or Italian language ability
  • participation in other study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual Care + Complementary MedicineIndividualized complementary medicine treatment-
Usual careIndividualized usual care-
Usual Care + Complementary MedicineIndividualized usual care-
Primary Outcome Measures
NameTimeMethod
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)6 months
Secondary Outcome Measures
NameTimeMethod
Satisfaction and patient-reported effectiveness3, 6 months

This will only be assessed in the complementary medicine arm

Survival6 months
Functional Assessment of Chronic Illness Therapy-Fatigue3, 6 months
Functional Assessment of Cancer Therapy-Breast quality of life instrument (FACT-B)3 months
Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)3, 6 months
Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being)3, 6 months
Used complementary Therapies and their frequency6 months

This will only be assessed in the complementary medicine arm

Pain, quality of sleep, and nausea (single items of the FACT-B)3, 6 months
Survival without relapse6 months
Quality of Life (SF-12 Health Survey)3, 6 months
Undesirable Effects and Interactions6 months
Goal Attainment Scale3 months

This outcome measures will only be assessed in the complementary medicine arm

Expectations at BaselineBaseline

This will only be assessed in the complementary medicine group

Trial Locations

Locations (1)

Meran Hospital - Dienst fuer Komplementaermedizin

🇮🇹

Meran, Italy

© Copyright 2025. All Rights Reserved by MedPath